Researchers at Stony Brook University in New York have demonstrated an ultrasound-based method to promote bone cell growth, and the technique could eventually lead to non-pharmacologic treatments of osteoporosis, fractures and other conditions involving bone loss.

Although a study that appeared in Lancet Oncology comparing colonoscopy and CT colonography concluded that both techniques could be acceptable for population-based screening for colorectal cancer, it may be too soon to confirm the true benefit of either approach, according to a commentary published in the July 17 edition of the American College of Physicians (ACP) Journal Club.

Contrast-enhanced cardiac MRI may help determine whether children who have had heart transplants are showing early signs of rejection, according to results of a pilot study published July 12 in the Journal of Heart and Lung Transplantation. The technique could reduce the need for these patients to undergo an invasive coronary angiogram every one to two years.

Edward Hospital & Health Services has installed 12 wireless DR systems from Carestream.

Breast cancer mortality statistics in Sweden appear to confirm studies that have reported minimal or no impact of screening mammography on breast cancer mortality among women aged 40 to 69, according to a study published July 17 in the Journal of The National Cancer Institute. However, two editorial commentaries challenged the researchers approach and outlined future directions that move beyond the current debate.

Citing a horrific statisticU.S. military veterans commit suicide at the rate of nearly 18 per dayRep. Charles B. Rangel (D-N.Y.) has introduced, together with Rep. Glenn Thompson (R-Pa.), new legislation that would allow vets the same access to interstate telemedicine as that which active service members currently enjoy.

In the continued efforts to identify peripheral biomarkers of Alzheimers disease (AD), a group of Australian researchers has published promising results in the area of blood-based protein biomarkers. The researchers identified a panel of plasma biomarkers that could help distinguish individuals with AD from cognitively healthy individuals with high sensitivity and specificity, according to a study published online July 16 in Archives of Neurology.

Looking to make good on previous promises to foster rather than hinder innovation in the medical device industry, the FDA has released draft guidance outlining its updated pre-Investigational Device Exemption (IDE) program. According to an item announcing the guidance in the July 13 Federal Register, the updating includes giving IDE a simpler name: the Pre-Submission Program.